Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

It could take several years for Moderna's pipeline to really pan out, analysts say. In the meantime, its Covid vaccine has yet to hit a bottom and its RSV vaccine is coming from behind in competition ...